$27.94
-1.50-5.10%
al cierre: -
$27.94
0.000.00%
After hour: Oct 17, 5:59 PM EDT
Comments
Loading...
Scholar Rock Holding Actividad de operaciones con información privilegiada
SRRKNASDAQ
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Scholar Rock Holding. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Scholar Rock Holding.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Scholar Rock Holding Corp los iniciados?
En Scholar Rock Holding Corp, la reciente actividad interna ha llamado la atención. Durante los últimos 30 días, los insiders han informado haber vendido un total de 3.35K acciones por valor de $102.85K, mientras tanto, los insiders han informó haber comprado un total de 500.44K acciones por un valor total de $18.81M.
Compras y ventas recientes notables de información privilegiada
- El octubre 7, 2025, Srinivas Akkaraju, la empresa - purchased 500.44K acciones por $37.58 cada una.
- El septiembre 17, 2025, Katie Peng, la empresa - sold 1.01K acciones por $32.53 cada una.
- El agosto 19, 2025, Caryn Parlavecchio, la empresa CHRO sold 2.18K acciones por $31.17 cada una.
Estadísticas de propiedad de Scholar Rock Holding Corp
Acciones en circulación
94.946M
Acciones en manos de personas con información privilegiada
8.891M
Porcentaje de acciones en manos de personas con información privilegiada
9.25%
Acciones en manos de instituciones
60.008M
Porcentaje de acciones en manos de instituciones
62.4%
Oct 07, 2025 | — | 500.44K | $37.58 | $18.81M | BUY | 9.44% | 5.80M | Oct 03 - Oct 06 | ||
Sep 24, 2025 | CHIEF SCIENTIFIC OFFICER | -3.35K | $30.67 | -$102.85K | SELL | -2.99% | 108.96K | Sep 22 | ||
Sep 17, 2025 | — | -1.01K | $32.53 | -$32.73K | SELL | -2.88% | 33.91K | Sep 16 | ||
Sep 17, 2025 | CHIEF SCIENTIFIC OFFICER | -3.18K | $33.52 | -$106.53K | SELL | -2.75% | 112.32K | Sep 16 | ||
Aug 19, 2025 | CHRO | -2.18K | $31.17 | -$67.88K | SELL | -1.38% | 155.46K | Aug 18 | ||
Jul 18, 2025 | — | -11.14K | $40.02 | -$445.69K | SELL | -31.63% | 24.07K | Jul 16 | ||
Jul 10, 2025 | CHIEF SCIENTIFIC OFFICER | -24.07K | $34.44 | -$828.90K | SELL | -17.24% | 115.50K | Jul 08 | ||
Jun 25, 2025 | — | -11.14K | $27.10 | -$585.49K | SELL | -50.00% | 11.14K | Jun 23 | ||
Jun 17, 2025 | — | -3.03K | $31.97 | -$96.89K | SELL | -7.99% | 34.92K | Jun 16 | ||
Jun 17, 2025 | CHIEF SCIENTIFIC OFFICER | -3.67K | $32.00 | -$117.38K | SELL | -2.56% | 139.56K | Jun 16 | ||
Jun 17, 2025 | CHRO | -6.19K | $32.00 | -$197.96K | SELL | -3.78% | 157.64K | Jun 16 | ||
Jun 17, 2025 | GENERAL COUNSEL | -7.44K | $32.00 | -$238.15K | SELL | -3.24% | 222.57K | Jun 16 | ||
May 30, 2025 | — | -6.08K | $29.73 | -$180.58K | SELL | -11.59% | 46.34K | May 29 | ||
May 30, 2025 | — | -5.40K | $29.72 | -$160.51K | SELL | -0.23% | 2.37M | May 29 | ||
May 30, 2025 | — | -3.38K | $29.72 | -$100.30K | SELL | -5.76% | 55.22K | May 29 | ||
May 30, 2025 | — | -6.08K | $29.72 | -$180.53K | SELL | -28.75% | 15.06K | May 29 | ||
May 30, 2025 | — | -5.40K | $29.72 | -$160.46K | SELL | -25.55% | 15.73K | May 29 | ||
May 30, 2025 | PRESIDENT R&D | -6.75K | $29.72 | -$200.61K | SELL | -1.08% | 616.21K | May 29 | ||
Apr 29, 2025 | CHIEF COMMERCIAL OFFICER | 0.00 | $21.41 | -$114.13K | SELL-OPTIONS | 0.00% | 71.75K | Apr 25 | ||
Mar 25, 2025 | CHIEF COMMERCIAL OFFICER | -1.50K | $21.54 | -$165.01K | SELL | -2.05% | 71.75K | Mar 24 | ||
Mar 25, 2025 | INTERIM PFO AND PAO | 0.00 | $25.23 | -$214.15K | SELL-OPTIONS | 0.00% | 82.61K | Mar 24 | ||
Mar 19, 2025 | — | -1.01K | $34.42 | -$34.63K | SELL | -3.21% | 30.32K | Mar 17 | ||
Mar 12, 2025 | COO & CFO | -29.39K | $24.61 | -$3.53M | SELL | -20.89% | 111.34K | Mar 10 | ||
Feb 20, 2025 | CHIEF SCIENTIFIC OFFICER | -24.34K | $23.78 | -$2.22M | SELL | -17.97% | 111.08K | Feb 18 - Feb 19 | ||
Feb 20, 2025 | CHRO | -5.30K | $36.83 | -$195.05K | SELL | -3.64% | 140.26K | Feb 18 | ||
Feb 20, 2025 | COO & CFO | -7.81K | $36.83 | -$287.60K | SELL | -5.26% | 140.74K | Feb 18 | ||
Feb 20, 2025 | GENERAL COUNSEL | -5.74K | $36.83 | -$211.47K | SELL | -2.94% | 189.29K | Feb 18 | ||
Feb 20, 2025 | CHIEF EXECUTIVE OFFICER | -18.37K | $36.83 | -$676.62K | SELL | -5.56% | 311.99K | Feb 18 | ||
Jan 21, 2025 | CHIEF EXECUTIVE OFFICER | -22.31K | $44.20 | -$985.95K | SELL | -6.33% | 330.36K | Jan 16 | ||
Jan 21, 2025 | CHIEF MEDICAL OFFICER | -5.66K | $44.20 | -$249.94K | SELL | -7.76% | 67.20K | Jan 16 | ||
Jan 21, 2025 | CHIEF COMMERCIAL OFFICER | -3.89K | $44.20 | -$171.93K | SELL | -7.89% | 45.40K | Jan 16 | ||
Jan 21, 2025 | CHIEF SCIENTIFIC OFFICER | -7.35K | $44.20 | -$324.72K | SELL | -5.15% | 135.42K | Jan 16 | ||
Jan 21, 2025 | CHRO | -6.43K | $44.20 | -$284.36K | SELL | -4.23% | 145.55K | Jan 16 | ||
Jan 21, 2025 | COO & CFO | -12.54K | $44.20 | -$554.19K | SELL | -7.78% | 148.55K | Jan 16 | ||
Jan 21, 2025 | GENERAL COUNSEL | -9.04K | $44.20 | -$399.50K | SELL | -4.43% | 195.04K | Jan 16 | ||
Dec 12, 2024 | — | -1.60M | $41.65 | -$66.64M | SELL | -14.75% | 9.25M | Dec 10 | ||
Nov 27, 2024 | — | -409.43K | $38.49 | -$15.76M | SELL | -3.64% | 10.85M | Nov 25 | ||
Nov 26, 2024 | CHIEF MEDICAL OFFICER | 0.00 | $22.83 | -$242.58K | SELL-OPTIONS | 0.00% | 72.86K | Nov 22 - Nov 25 | ||
Nov 13, 2024 | CHIEF MEDICAL OFFICER | 0.00 | $19.30 | -$45.08K | SELL-OPTIONS | 0.00% | 72.86K | Nov 11 | ||
Oct 10, 2024 | COO & CFO | 0.00 | $22.45 | -$925.79K | SELL-OPTIONS | 0.00% | 161.09K | Oct 08 | ||
Oct 07, 2024 | COO & CFO | -412.48K | $20.19 | -$8.33M | SELL | -71.91% | 161.09K | Oct 07 | ||
Oct 07, 2024 | CHIEF COMMERCIAL OFFICER | 0.00 | $17.81 | -$468.68K | SELL-OPTIONS | 0.00% | 49.28K | Oct 07 | ||
Oct 07, 2024 | — | -1.18M | $29.25 | -$34.39M | SELL | -17.28% | 5.63M | Oct 07 | ||
Oct 07, 2024 | CHIEF MEDICAL OFFICER | 0.00 | $17.90 | -$2.04M | SELL-OPTIONS | 0.00% | 72.86K | Oct 07 | ||
Sep 19, 2024 | CHIEF SCIENTIFIC OFFICER | -1.94K | $8.58 | -$16.61K | SELL | -1.34% | 142.77K | Sep 16 | ||
Aug 19, 2024 | CHRO | -1.45K | $9.33 | -$13.54K | SELL | -0.95% | 151.99K | Aug 16 | ||
Jun 18, 2024 | CHIEF SCIENTIFIC OFFICER | -2.31K | $8.98 | -$20.80K | SELL | -1.57% | 144.70K | Jun 17 | ||
Jun 18, 2024 | CHRO | -4.30K | $8.98 | -$38.68K | SELL | -2.73% | 153.44K | Jun 17 | ||
Jun 18, 2024 | COO & CFO | -9.46K | $8.98 | -$84.98K | SELL | -4.48% | 201.52K | Jun 17 | ||
Jun 18, 2024 | GENERAL COUNSEL | -4.70K | $8.98 | -$42.18K | SELL | -2.25% | 204.08K | Jun 17 | ||
Feb 21, 2024 | COO & CFO | -4.74K | $15.74 | -$74.69K | SELL | -2.20% | 210.98K | Feb 16 | ||
Feb 20, 2024 | CHIEF SCIENTIFIC OFFICER | -2.51K | $15.74 | -$39.55K | SELL | -1.68% | 147.02K | Feb 16 | ||
Feb 20, 2024 | CHRO | -3.75K | $15.74 | -$59.05K | SELL | -2.32% | 157.74K | Feb 16 | ||
Feb 20, 2024 | GENERAL COUNSEL | -3.49K | $15.74 | -$54.93K | SELL | -1.64% | 208.77K | Feb 16 | ||
Feb 20, 2024 | CHIEF EXECUTIVE OFFICER | -11.61K | $15.74 | -$182.84K | SELL | -3.19% | 352.67K | Feb 16 | ||
Jan 18, 2024 | SVP AND HEAD OF RESEARCH | -2.00K | $15.93 | -$31.89K | SELL | -2.48% | 78.82K | Jan 16 | ||
Jan 18, 2024 | CHRO | -2.85K | $15.93 | -$45.38K | SELL | -2.43% | 114.35K | Jan 16 | ||
Jan 18, 2024 | COO & CFO | -6.63K | $15.93 | -$105.67K | SELL | -3.93% | 162.15K | Jan 16 | ||
Jan 18, 2024 | GENERAL COUNSEL | -4.19K | $15.93 | -$66.68K | SELL | -2.64% | 154.41K | Jan 16 | ||
Dec 29, 2023 | COO & CFO | 0.00 | $11.85 | -$174.08K | SELL-OPTIONS | 0.00% | 168.78K | Dec 29 | ||
Dec 15, 2023 | SVP AND HEAD OF RESEARCH | -16.23K | $14.09 | -$364.07K | SELL | -16.72% | 80.82K | Dec 14 | ||
Dec 08, 2023 | COO & CFO | 0.00 | $11.20 | -$315.74K | SELL-OPTIONS | 0.00% | 168.78K | Dec 07 | ||
Nov 03, 2023 | COO & CFO | -35.01K | $12.51 | -$438.04K | SELL | -17.18% | 168.78K | Nov 02 | ||
Oct 18, 2023 | DIRECTOR | 2.19M | $6.85 | $15.00M | BUY | 47.62% | 6.79M | Oct 16 | ||
Oct 18, 2023 | 10% OWNER | 2.19M | $6.85 | $15.00M | BUY | 47.62% | 6.79M | Oct 16 | ||
Oct 16, 2023 | — | 2.20M | $6.86 | $15.09M | BUY | 24.28% | 11.26M | Oct 12 | ||
Sep 20, 2023 | SVP AND HEAD OF RESEARCH | -1.95K | $6.34 | -$12.33K | SELL | -1.96% | 97.04K | Sep 18 | ||
Aug 18, 2023 | CHRO | -1.35K | $6.83 | -$9.24K | SELL | -1.14% | 117.20K | Aug 16 | ||
May 02, 2023 | 10% OWNER | 31.56K | $6.43 | $202.85K | BUY | 0.35% | 9.06M | Apr 28 | ||
Jan 11, 2023 | 10% OWNER | -1.09K | $9.48 | -$10.37K | SELL | -0.01% | 9.03M | Jan 09 | ||
Jan 09, 2023 | 10% OWNER | 48.77K | $9.33 | $455.09K | BUY | 0.54% | 9.03M | Jan 05 | ||
Oct 27, 2022 | 10% OWNER | 130.26K | $8.04 | $1.05M | BUY | 1.47% | 8.98M | Oct 25 | ||
Oct 07, 2022 | 10% OWNER | 99.97K | $7.60 | $759.55K | BUY | 1.14% | 8.85M | Oct 03 - Oct 04 | ||
Jun 24, 2022 | DIRECTOR | 1.20M | $4.90 | $5.87M | BUY | ∞ | 214.34K | Jun 22 | ||
Nov 15, 2021 | CHIEF FINANCIAL OFFICER | 0.00 | $35.14 | -$2.75M | SELL-OPTIONS | 0.00% | 24.15K | Nov 11 - Nov 15 | ||
Oct 05, 2021 | DIRECTOR | -6.00K | $30.89 | -$185.33K | SELL | -21.22% | 22.27K | Oct 01 | ||
Sep 21, 2021 | DIRECTOR | -500.00 | $34.09 | -$17.05K | SELL | -5.26% | 9.01K | Sep 20 | ||
Jul 28, 2021 | DIRECTOR | -6.00K | $31.66 | -$189.95K | SELL | -17.51% | 28.27K | Jul 26 | ||
Mar 17, 2021 | DIRECTOR | -4.70K | $65.59 | -$308.00K | SELL | -11.14% | 37.46K | Mar 15 | ||
Feb 11, 2021 | DIRECTOR | -1.80K | $65.06 | -$117.36K | SELL | -4.10% | 42.16K | Feb 08 | ||
Jan 28, 2021 | DIRECTOR | 0.00 | $32.51 | -$187.27K | SELL-OPTIONS | 0.00% | 43.96K | Jan 26 | ||
Jan 28, 2021 | HEAD RESEARCH | -18.36K | $34.20 | -$2.89M | SELL | -40.59% | 26.86K | Jan 26 - Jan 27 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.